[go: up one dir, main page]

WO2019112609A1 - Suspension de biopolymère pompable et/ou fluidifiable - Google Patents

Suspension de biopolymère pompable et/ou fluidifiable Download PDF

Info

Publication number
WO2019112609A1
WO2019112609A1 PCT/US2017/065331 US2017065331W WO2019112609A1 WO 2019112609 A1 WO2019112609 A1 WO 2019112609A1 US 2017065331 W US2017065331 W US 2017065331W WO 2019112609 A1 WO2019112609 A1 WO 2019112609A1
Authority
WO
WIPO (PCT)
Prior art keywords
solution
suspension
mass
filter
paper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2017/065331
Other languages
English (en)
Inventor
Jeffrey J. MALSAM
Eric Stanley SUMNER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cargill Inc
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Priority to PCT/US2017/065331 priority Critical patent/WO2019112609A1/fr
Publication of WO2019112609A1 publication Critical patent/WO2019112609A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K8/00Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
    • C09K8/58Compositions for enhanced recovery methods for obtaining hydrocarbons, i.e. for improving the mobility of the oil, e.g. displacing fluids
    • C09K8/588Compositions for enhanced recovery methods for obtaining hydrocarbons, i.e. for improving the mobility of the oil, e.g. displacing fluids characterised by the use of specific polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00

Definitions

  • the present invention relates to the preparation of a pumpable and/or flowable beta glucan suspension that achieves desired filterability and viscosity build for enhanced oil recovery applications.
  • Beta glucans are widely used as thickeners in enhanced oil recovery (EOR) applications. Particularly in off-shore applications, there is a desire to utilize such beta glucans, however given the limited amount of real estate it is desirable to receive the beta glucan in solid or suspended form, quickly solubilize or dilute using the water on hand and minimal equipment, wherein the solubilization/dilution procedure provides desirable properties, for example filterability and viscosity, necessary for enhanced oil recovery operations.
  • the major drawback of scleroglucan polymer (a beta glucan) is its poor solubilization. Methods have been investigated and studied in this regard, however each of these methods have presented limitations.
  • Described herein is a pumpable and/or flowable suspension comprising about 10-
  • BG beta glucan
  • BG beta glucan
  • Such diluted suspension has desired viscosity build and filterability properties for EOR applications.
  • Average residence time is defined as the holdup volume of the shear element divided by the average flow rate through the shear element in seconds.
  • Flowable is defined as a suspension that retains at least 80% of the beta glucan solids when transferred according to the Transfer Procedure. As described herein, the suspension is pumpable and/or flowable.
  • “Particle Size Distribution” is defined as the mass-median-diameter of the BG powder.
  • “Pumpable” is defined as a suspension having a viscosity ranging from 0.1 to 2 million cP at 70°C measured at 100 s 1 of shear. As described herein, the suspension is pumpable and/or flowable.
  • Shear duration is defined as average residence time (in seconds) in the shear element multiplied by the shear rate (inverse seconds).
  • Solid is defined as a solid (i.e., not a liquid or gas) at standard atmospheric conditions.
  • solid includes powders, pressed or wet cakes, and solids surrounded by an alcohol solution or hydrophobic liquid.
  • “Suspension” is defined as a stable or unstable, heterogeneous mixture of solid or semi-solid beta glucan particles and a carrier fluid.
  • a pumpable and/or flowable suspension of beta glucan that when diluted, under a specified dilution procedure, builds viscosity faster than existing commercially available beta glucan materials, provides higher filterability with minimal processing than existing commercially available beta glucan materials, and maintains viscosity throughout filterability testing.
  • the beta glucans (“BG”) described herein include polysaccharides classified as 1,3 beta-D-glucans, i.e., any polysaccharide which has a beta-(l,3)-linked backbone of D- glucose residues, and modifications thereof.
  • the beta glucan described herein comprises a repeat unit defined as 3 beta-l,3-glycosidically bonded glucose units and one beta-l,6-glycosidically glucose side unit typically connected to the middle beta- 1,3 glucose.
  • the beta glucan described herein comprises at least 90% of that repeat unit in its polymeric chain.
  • Fungal strains which secrete such glucans are known to those skilled in the art. Examples comprise Schizophyllum ses, Sclerotium rolfsii, Sclerotium glucanicum, Monilinla fructigena, Lentinula edodes or Botrygs cinera.
  • the fungal strains used are preferably Schizophyllum commune or Sclerotium rolfsii.
  • 1,3 beta-D-glucans examples include curdlan (a homopolymer of beta- (l,3)-linked D-glucose residues produced from, e.g., Agrobacterium spp.), grifolan (a branched beta-(l,3)-D-glucan produced from, e.g., the fungus Grifola frondosa), lentinan (a branched beta-(l,3)-D-glucan having two glucose branches attached at each fifth glucose residue of the beta-(l,3)-backbone produces from, e.g., the fungus Lentinus eeodes), schizophyllan (a branched beta-(l,3)-D-glucan having one glucose branch for every third glucose residue in the beta-(l,3)- backbone produced from, e.g., the fungus Schizophyllan commune), scleroglucan (a branched beta-(l,3)-D-glucan with one out of curdlan (a
  • beta glucans i.e., beta glucans comprising a main chain from beta-l,3-glycosidically bonded glucose units and side groups which are formed from glucose units and are beta-l,6-glycosidically bonded thereto, and modifications are used herein.
  • beta glucans are scleroglucan and schizophyllan.
  • solid beta glucan as described above, may be included in a suspension to obtain a pumpable and/or flowable suspension of beta glucan.
  • the carrier fluid for the suspension can generally be any fluid that will suspend or partially a dispersion of solid beta glucan material.
  • the beta glucan must not be readily soluble in the carrier fluid or the concentrated suspension may become too viscous (i.e., exceeds 2 million cP at 25°C). It is also desirable to limit the hydration characteristics of the carrier fluid to limit hydration of the beta glucan being suspended. It shall also be understood that the particle size of the beta glucan will impact viscosity and other properties of the suspension. Accordingly, in creating the suspension, there is a balance between having larger beta glucan particle size (which may aid in the flowability of the suspension) and perhaps selecting a smaller beta glucan particle size (which may aid in solubilization).
  • the beta glucan suspension may be amphiphilic, hydrophobic, or hydrophilic.
  • Five preferred types of suspensions are contemplated herein: (1) solid beta glucan material in an immiscible hydrophobic carrier, (2) mixture of solid beta glucan material and alcohol in a hydrophobic carrier, (3) mixture of alcohol, water, and solid beta glucan material in alcohol, (4) solid beta glucan material in a hydrophobic system with reintroduced water, or (5) solid beta glucan material dispersed in an alcohol.
  • the carrier fluid can include various alcohols (for example, butanol, heptane, hexane, octanol, pentanol, and isopropyl alcohol), glycols and glycol ethers such as ethylene glycol monobutyl ether (EGMBE), hexylene glycol, 2-methyl hexanol, propylene glycol n-butyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, dipropylene glycol methyl ether, dipropylene glycol n-butyl ether, diethylene glycol ethyl ether, propylene glycol, diethylene glycol methyl ether, and the like.
  • GMBE ethylene glycol monobutyl ether
  • hexylene glycol 2-methyl hexanol
  • propylene glycol n-butyl ether ethylene glycol methyl ether
  • ethylene glycol ethyl ether
  • the carrier fluid can include hydrophobic, non-water soluble organic liquids, particularly those having a Log Ko value ranging from 0.1-10 and more preferably 0.3- 8.5, wherein Ko is the partition coefficient of a hydrophobic material in water.
  • hydrophobic liquids may be hydrocarbons such as alkenes (paraffins, isoparaffins) having the molecular formula C n H2 n+ 2, alkenes (olefins, alpha olefins, polyalphaolefins) having the molecular formula C n tk n , various petroleum fractions such as mineral oils, diesel oil, white oils, and the like.
  • water insoluble organic liquids which may be useful in this invention are terpenes, vegetable oils, carboxylic esters, malonic esters, sulfonic esters, limonene, alcohols containing 6 to 10 carbon atoms, and the like.
  • the carrier fluid can be in a single-phase system or a multi-phase system.
  • the suspension comprises about 10-60 wt% beta glucan, more preferably 20-50 wt%, more preferably 30-40 wt%, more preferably 35-45 wt%, and even more preferably 35-40 wt%.
  • the suspension optionally can comprise one or more suspension, dispersing, or thinning agents and optionally may comprise a biocide.
  • the pumpable and/or flowable beta glucan suspension described herein has desirable properties for EOR applications.
  • the beta glucan suspension achieves a filterability ratio ranging from about 1 to 2, preferably from about 1 to 1.5, and even more preferably a filterability ratio from about 1 to 1.2.
  • the specified dilution procedure generally involves dispersing the beta glucan suspension into an aqueous solution and subjecting said resulting solution to relatively high shear.
  • the equipment and procedures utilized to dilute the beta glucan suspension are suitable for off shore EOR applications and accommodate the limited real estate typically available in off shore EOR applications.
  • Dilution of the beta glucan suspension can be carried out in either salt water or fresh water. Further, dilution may occur in pH conditions ranging from about 6 to about 8, and in temperature conditions ranging from about l0°C to l20°C, in preferred aspects from 80°C to l20°C, and in other preferred aspects from 20°C to about 40°C. Dilution is achieved via an in line shear device.
  • the high shear system comprises at least one high shear element. In other aspects, the high shear system comprises at least two or at least three high shear elements. In aspects wherein there are multiple high shear elements, the shear elements are in series.
  • the shear rate ranges from about 40,000/s to 300,000/s, more preferably from about 100, 000/s to 300,000/s, more preferably from about 100, 000/s to 250,000/s, and even more preferably from about 170, 000/s to 225,000/s.
  • the shear can be applied via many approaches known to one familiar in the art, including moving parts like a rotor-stator pair or a colloidal mixer or static devices like an orifice plate or a narrow tube with high velocity flow.
  • the dilution can require between 1 and 6 passes through the shear device. Multiple passes, e.g., greater than one pass could be required if viscosity continues to rise, with final dilution occurring after a consistent or slightly dropping viscosity on two consecutive passes.
  • the rate of the shear can be increased by at least 25% between shear elements.
  • the average residence time in which the suspension is subject to shear is less than ten seconds, in some aspects less than 5 seconds, and in other aspects less than 1 second. Further, the shear during is less than 250,000. In some aspects, the overall time from initial shear to final shear completion is less than 5 minutes and more preferably less than 1 minute. This overall time includes time spent between shear elements.
  • beta glucan material can be recycled back through the high shear system, and in preferred aspects, less than 10 wt% of BG material can be recycled back through the high shear system.
  • the beta glucan suspension described herein has a purity sufficient enough that greater than 42%, and in most aspects greater than 50% of ultimate viscosity can be recovered after running the specified dilution procedure for one pass and greater than 70% after two passes. In preferred aspects, greater than 60%, greater than 70%, and even greater than 80% of ultimate viscosity is achieved after running the specified dilution procedure for one pass. In additional preferred aspects, greater than 80%, and even greater than 90% of ultimate viscosity is achieved after running the specified dilution procedure for two passes. Ultimate viscosity as described herein typically ranges from about 2 cP to about 1000 cP and in preferred aspects ranges from about 50 cP to about 200 cP.
  • beta glucan suspension described herein achieves less than 15% viscosity loss during filtration, in preferred aspects has less than 10% viscosity loss, and in more preferred aspects less than 5% viscosity loss during filtration.
  • the pumpable and/or flowable beta glucan suspension described herein may further include a surfactant.
  • the surfactant is an anionic surfactant.
  • Anionic surfactants are desirable because of their strong surfactant properties, they are relatively stable, they exhibit relatively low adsorption on reservoir rock, and can be manufactured economically.
  • Typical anionic surfactants are sulfates for low temperature EOR applications and sulfonates, and more specifically sulfonated hydrocarbons, for high temperature EOR applications.
  • Crude oil sulfonates is a product when a crude oil is sulfonated after it’s been topped
  • petroleum sulfonates is a product when an intermediate-molecular-weight refinery stream is sulfonated
  • synthetic sulfonates is a product when a relatively purse organic compound is sulfonated.
  • Cationic and nonionic surfactants while not as desirable as anionic surfactants, may also be used primarily as a cosurfactants to improve the behavior of surfactant systems.
  • the surfactant in the pumpable and/or flowable beta glucan suspension described herein may be generated prior to its inclusion into the pumpable and/or flowable beta glucan suspension or alternatively may be generated in situ. It shall also be understand that surfactant floods having a pH ranging from 9-10 are likely more compatible with the pumpable and/or flowable beta glucan suspension described herein.
  • the elapsed time between the beginning of Step 4 and the end of Step 7 of the Specified Dilution Procedure should take between 30 minutes and 2 hours.
  • the elapsed time between the beginning of Step 4 of the Standard Dilution Procedure and the end of Step 9 of the Filtration Procedure should take between 30 minutes and 4 hours.
  • Viscosity measurements were done on degassed samples using a Brookfield Ametek® LVT (spindle 1, 12, 30, and 60 rpm) viscometer, referenced as LVT.
  • the homogenized mixture is cooled to 50°C. 4 g/L of CaCl 2 *2EbO was added. pH is reduced to 1.81 using 20% HC1. This mixture is agitated for 30 minutes to enable precipitation of oxalic acid.
  • the solution is fed to a clean Choquenet 12 m 2 press filter with Sefar Fyltris 25080 AM filter clothes at 1400 L/hr recycling the product back to the feed tank for 10 minutes.
  • the flow is adjusted to 1300 L/hr and passed through the filter. Once the tank is empty an additional 50 liters of water is pushed into the filter. The fluid from this water flush and a 12 bar compression of the cake is both added to the collected permeate.
  • the filter is cleaned after use.
  • the heated mixture has 6 kg of Dicalite 4158 added and mixed for 10 minutes.
  • this solution is recycled through a clean Choquenet 12 m 2 press filter with Sefar Fyltris 25080 AM filter clothes at 1400 L/hr for 15 minutes. After the recycle, the tank is passed through the filter at 1400 L/hr.
  • the heated mixture has 6 kg of Dicalite 4158 added and mixed for 10 minutes. At 1400 L/hr this solution is recycled through a clean Choquenet 12 m 2 press filter with Sefar Fyltris 25080 AM filter clothes at 1400 L/hr for 15 minutes. After the recycle, the tank is passed through the filter at 1450 L/hr.
  • the triple filtered permeate is cooled to 60 °C and mixed with 83% IPA at a 1:2 ratio, 2 g IPA solution for each g of scleroglucan solution.
  • a tromel separator is used to partition the precipitated fibers from the bulk liquid solution.
  • Example 2 20% BG Suspension in Mineral Oil
  • a mineral oil suspension was made blending the beta glucan from example 1 and mineral oil (Sigma Aldrich Ml 180-4L). Mass measurements of both components were made and samples were manually stirred into a beaker to have 20% BG solids and 80% mineral oil.
  • the filterability ratio of the 6 pass material was 1.32.
  • Example 3 40% BG Suspension in Mineral Oil
  • a mineral oil suspension was made blending the beta glucan from example 1 and mineral oil (Sigma Aldrich Ml 180-4L). Mass measurements of both components were made and samples were manually stirred into a beaker to have 40% BG solids and 60% mineral oil.
  • the filterability ratio of the 6 pass material was 1.12.
  • Filterability of material after 12 passes using the filterability procedure was 1.15.
  • the measured solids fraction of the transferred solution is 34% and in the initial solution is 35%. This is a measured recovery of 97%.
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 35% and in the initial solution is 35%. This is a measured recovery of 100%.
  • Example 7 Flowabilitv of 35% Actigum® CS11 in n-Octanol
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 32% and in the initial solution is 35%. This is a measured recovery of 91%.
  • Example 8 Flowabilitv of 35% Actigum® CS11 in n-Pentanol
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 33% and in the initial solution is 35%. This is a measured recovery of 94%.
  • Example 9 Flowabilitv of 35% Actigum® CS11 in isopropyl alcohol
  • Example 10 Flowabilitv of 35% Actigum® CS11 in n-Butanol
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 33% and in the initial solution is 35%. This is a measured recovery of 94%.
  • Example 11 Flowabilitv of 35% Actigum® CS11 in mineral nil [000111]
  • ASTM E960 beaker add 61.3g of CS11 to 113.8g of Sigma- Aldrich® Ml 180 mineral oil, a 35% solution.
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 31% and in the initial solution is 35%. This is a measured recovery of 88%.
  • Example 12 Flowabilitv of 35% Actigum® CS11 in Tween® 20 [000119]
  • a 600 mL low form ASTM E960 beaker add 61.3g of CS11 to H3.9g of Tween® 20, a 35% solution.
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 30% and in the initial solution is 35%. This is a measured recovery of 85%.
  • Example 13 Flowabilitv of 35% Actigum® CS11 in Dipropylene glycol methyl ether
  • the measured solids fraction of the transferred solution is 32% and in the initial solution is 35%. This is a measured recovery of 91%.
  • Example 15 Flowabilitv of 55% Actigum® CS11 in n-Heptane
  • the measured solids fraction of the transferred solution is 48% and in the initial solution is 55%. This is a measured recovery of 87%.
  • the measured masses are:
  • Example 17 Flowabilitv of 40% Actigum® CS11 in n-Butanol
  • the measured solids fraction of the transferred solution is 37% and in the initial solution is 40%. This is a measured recovery of 92.5%.
  • Example 18 Flowabilitv of 35% Actigum® CS11 in 90% n-Butanol and 10% H2Q
  • the measured masses are:
  • the measured solids fraction of the transferred solution is 32% and in the initial solution is 35%. This is a measured recovery of 91%.
  • Example 19 Flowabilitv of 30% Beta Glucan as Described in Example 1 in 90% n-Butanol and 10% H2Q
  • the measured solids fraction of the transferred solution is 28% and in the initial solution is 30%. This is a measured recovery of 93%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne une suspension pompable et/ou fluidifiable comprenant environ 10 à 60 % en poids de bêta-glucane (BG) qui, lorsqu'elle est diluée, permet d'obtenir un rapport de filtrabilité compris entre 1 et 2, de préférence 1,5 et une suspension pompable et/ou fluidifiable dans laquelle plus de 50 % de la viscosité finale peut être récupérée après une opération de dilution spécifiée pour un passage et plus de 70 % de viscosité finale après deux passages. Une telle suspension diluée présente des propriétés de filtrabilité et de viscosité désirée pour des applications EOR.
PCT/US2017/065331 2017-12-08 2017-12-08 Suspension de biopolymère pompable et/ou fluidifiable Ceased WO2019112609A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2017/065331 WO2019112609A1 (fr) 2017-12-08 2017-12-08 Suspension de biopolymère pompable et/ou fluidifiable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/065331 WO2019112609A1 (fr) 2017-12-08 2017-12-08 Suspension de biopolymère pompable et/ou fluidifiable

Publications (1)

Publication Number Publication Date
WO2019112609A1 true WO2019112609A1 (fr) 2019-06-13

Family

ID=66750286

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/065331 Ceased WO2019112609A1 (fr) 2017-12-08 2017-12-08 Suspension de biopolymère pompable et/ou fluidifiable

Country Status (1)

Country Link
WO (1) WO2019112609A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250436A (en) * 1984-11-28 1993-10-05 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US20050245480A1 (en) * 2002-08-13 2005-11-03 Biopolymer Engineering, Inc. Methods of using beta glucan as a radioprotective agent
WO2017172719A1 (fr) * 2016-03-28 2017-10-05 Cargill, Incorporated Procédé de solubilisation de solides biopolymères pour des applications améliorées de récupération du pétrole
WO2017214492A2 (fr) * 2016-06-10 2017-12-14 Cargill, Incorporated Suspension de biopolymère pompable et/ou fluide

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250436A (en) * 1984-11-28 1993-10-05 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US20050245480A1 (en) * 2002-08-13 2005-11-03 Biopolymer Engineering, Inc. Methods of using beta glucan as a radioprotective agent
WO2017172719A1 (fr) * 2016-03-28 2017-10-05 Cargill, Incorporated Procédé de solubilisation de solides biopolymères pour des applications améliorées de récupération du pétrole
WO2017214492A2 (fr) * 2016-06-10 2017-12-14 Cargill, Incorporated Suspension de biopolymère pompable et/ou fluide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VOLMAN ET AL.: "Dietary modulation of immune function by B-glucans", PHYSIOLOGY & BEHAVIOR, vol. 94, no. 2, 23 May 2008 (2008-05-23), pages 276 - 284, XP022648008, DOI: doi:10.1016/j.physbeh.2007.11.045 *

Similar Documents

Publication Publication Date Title
RU2727472C2 (ru) Способ и установка для обработки растительного сырья посредством ферментативного гидролиза
CA2952903C (fr) Compositions comprenant du materiau particulaire cellulosique parenchymal
EP3469006A2 (fr) Suspension de biopolymère pompable et/ou fluide
WO2012071056A2 (fr) Procédés de surveillance de transformation de guar
WO2019059901A1 (fr) Solides biopolymères solubles et filtrables
WO2019112609A1 (fr) Suspension de biopolymère pompable et/ou fluidifiable
SI24656A (sl) Metoda za izdelavo nanokristalinične celuloze
WO2016075370A1 (fr) Cellulose parenchymale cationique
CN106459827A (zh) 用于纯化精制的脂质相的方法
CN105482787B (zh) 一种利用厌氧发酵沼渣制备水基钻井液降滤失剂的捏合工艺方法
Wang et al. Ultrasonic treatment of α-chitin regenerated from a NaOH/urea solvent with tunable capacity for stabilization of oil in water emulsion
US20190112518A1 (en) Method for solubilizing biopolymer solids for enhanced oil recovery applications
WO2018226968A1 (fr) Suspension de biopolymère gonflable et dispersible
US20190106618A1 (en) Soluble & filterable biopolymer solids
EP3601374A1 (fr) Bêta-glucanes raffinés et procédés de fabrication de ceux-ci
CN120795306B (zh) 一种绿色环保的聚醚类破乳剂及其制备方法
US20200115622A1 (en) Process for thermal degradation of a biopolymer
JPH08231603A (ja) カルボキシメチルセルロースエーテルアルカリ塩の改質方法およびそれにより得られたカルボキシメチルセルロースエーテルアルカリ塩
Li et al. Rheological Behavior of Aqueous Solutions of Cationic Guar in Presence of Oppositely Charged Surfactant
WO2018183014A1 (fr) Suspensions de bêta-glucane facilement miscibles à l'eau
EP3601430A1 (fr) Suspensions de bêta-glucane facilement miscibles dans l'eau
EP3801453A1 (fr) Sel de métal alcalin d'éther de carboxyalkyle de gomme de tamarin à composition améliorée

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17933875

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17933875

Country of ref document: EP

Kind code of ref document: A1